← Back to contracts

DoW, Peer Reviewed Cancer, Impact Award

US Dept › of the Army -- U › S › Army Medical Research Acquisition Activity (USAMRAA) grant open #HT942526PRCRPIPA
Response due Oct 05, 2026 · 00:00 UTC

Summary

The U.S. Army Medical Research Acquisition Activity (USAMRAA) under the Department of the Army is soliciting applications for the Peer Reviewed Cancer Research Program (PRCRP) Impact Award. This is a Department of Defense (DoD) peer-reviewed cancer research funding opportunity. The award is intended to support impactful cancer research initiatives as part of the congressionally directed medical research program. Further scope details (research focus areas, funding limits, eligibility) are not specified in the available synopsis text.

How they evaluate

Submission: Grants.gov federal grants portal

Risks & flags

  • Synopsis text is extremely sparse — no scope details, funding amount, eligibility criteria, or research focus areas are provided, making competitive assessment impossible from this record alone.
  • Opportunity number (HT942526PRCRPIPA) suggests a pre-assigned instrument number, which may indicate an anticipated award structure already in place.

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541714
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW, Peer Reviewed Cancer, Impact Award
Due Oct 05
Onboard